Vitamin K2 supplementation improves impaired glycemic homeostasis and insulin sensitivity for type 2 diabetes through gut microbiome and fecal metabolites
Zhang Y, Liu L, Wei C, et al.
BMC Med. 2023;21(1):174.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Glycemia Risk Index as a novel metric to evaluate the safety of glycemic control in children and adolescents with Type 1 Diabetes: an observational, multicenter, real-life cohort study.
Piona C, Marigliano M, Roncarà C, et al.
Diabetes Technol Ther. Pub. online 8 May 2023.
Leggi
Treatment of gestational diabetes mellitus diagnosed early in pregnancy
Simmons D, Immanuel J, Hague WM, et al.
N Engl J Med. Pub. online 5 May 2023.
Leggi
Comparison of accuracy of Freestyle Libre Pro and Medtronic iPro2 continuous glucose monitoring systems in pregnancy
Golla KK, Gupta Y, Goyal A, et al.
Diabetes Technol Ther. Pub. online 27 Apr 2023.
Leggi
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: a pilot prospective study. GLISCAR Study
Palmiero G, Cesaro A, Galiero R, et al.
Diabetes Res Clin Pract. 2023;110686.
Leggi
Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry
Chetboun M, Drumez E, Ballou C, et al.
Lancet Diabetes Endocrinol. 2023;S2213-8587(23)00082-7.
Leggi
Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial
Verrastro O, Panunzi S, Castagneto-Gissey L, et al.
Lancet. 2023;S0140-6736(23)00634-7.
Leggi
Diabetes and anti-diabetic interventions and the risk of gynaecological and obstetric morbidity: an umbrella review of the literature
Semertzidou A, Grout-Smith H, Kalliala I, et al.
BMC Med. 2023;21(1):152.
Leggi
Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: the randomized, controlled EMPA-VISION trial
Hundertmark MJ, Adler A, Antoniades C, et al.
Circulation. Pub. online 18 Apr 2023.
Leggi
ChatGPT’s response to the diabetes knowledge questionnaire: implications for diabetes education
Nakhleh A, Spitzer S, Shehadeh N
Diabetes Technol Ther. Pub. online 16 Apr 2023.
Leggi